CHINA SXT PHARMACEUTICALS IN's ticker is and the CUSIP is G2161P132. A total of 6 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Renaissance Technologies | 10,540 | $2 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| ACADIAN ASSET MANAGEMENT LLC | 105,039 | $23 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 20,564 | $4,833 | 0.00% |
| Cetera Advisor Networks LLC | 10,415 | $2,448 | 0.00% |